- Home
- CBL vs MRVI Comparison
CBL vs MRVI Comparison
Compare CBL & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBL
- MRVI
- Stock Information
- Founded
- CBL 1978
- MRVI 2020
- Country
- CBL United States
- MRVI United States
- Employees
- CBL 469
- MRVI N/A
- Industry
- CBL Real Estate Investment Trusts
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- CBL Real Estate
- MRVI Health Care
- Exchange
- CBL Nasdaq
- MRVI Nasdaq
- Market Cap
- CBL 961.6M
- MRVI 795.7M
- IPO Year
- CBL 1993
- MRVI 2020
- Fundamental
- Price
- CBL $31.31
- MRVI $4.11
- Analyst Decision
- CBL
- MRVI Buy
- Analyst Count
- CBL 0
- MRVI 10
- Target Price
- CBL N/A
- MRVI $10.28
- AVG Volume (30 Days)
- CBL 177.2K
- MRVI 2.2M
- Earning Date
- CBL 02-14-2025
- MRVI 02-25-2025
- Dividend Yield
- CBL 8.96%
- MRVI N/A
- EPS Growth
- CBL 999.46
- MRVI N/A
- EPS
- CBL 1.87
- MRVI N/A
- Revenue
- CBL $515,561,000.00
- MRVI $276,920,000.00
- Revenue This Year
- CBL N/A
- MRVI N/A
- Revenue Next Year
- CBL N/A
- MRVI $1.93
- P/E Ratio
- CBL $17.08
- MRVI N/A
- Revenue Growth
- CBL N/A
- MRVI N/A
- 52 Week Low
- CBL $20.97
- MRVI $3.93
- 52 Week High
- CBL $33.54
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- CBL 56.57
- MRVI 35.37
- Support Level
- CBL $31.37
- MRVI $4.05
- Resistance Level
- CBL $32.37
- MRVI $4.40
- Average True Range (ATR)
- CBL 0.80
- MRVI 0.31
- MACD
- CBL 0.11
- MRVI -0.05
- Stochastic Oscillator
- CBL 38.65
- MRVI 15.38
About CBL CBL & Associates Properties Inc.
CBL & Associates Properties Inc is a U.S.-based real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.